Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy

Overview of attention for article published in Cancer Nanotechnology, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,908 followers.

RT @CancerNanotech: NEW: "Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy" https://t.co/YWtJZwZC…

NEW: "Nanoparticles advanced from preclinical studies to clinical trials for lung cancer therapy" https://t.co/YWtJZwZCah

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.